2004
DOI: 10.1093/ajhp/61.13.1380
|View full text |Cite
|
Sign up to set email alerts
|

Reported medication errors associated with methotrexate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
39
0
2

Year Published

2004
2004
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 58 publications
(41 citation statements)
references
References 0 publications
0
39
0
2
Order By: Relevance
“…Polypharmacy also played a role in 72% of the cases described by Moore et al 30 (mean number of drugs = 3.5). Our patient was taking 12 medications, which could have been another determining risk factor for a potential medication error.…”
Section: Discussionmentioning
confidence: 87%
See 1 more Smart Citation
“…Polypharmacy also played a role in 72% of the cases described by Moore et al 30 (mean number of drugs = 3.5). Our patient was taking 12 medications, which could have been another determining risk factor for a potential medication error.…”
Section: Discussionmentioning
confidence: 87%
“…[26][27][28] In 2002, the Institute for Safe Medication Practices released an advisory because reports had been made about methotrexate overdose with inadvertent administration of methotrexate daily instead of weekly. 29 Two years later, Moore et al 30 reported that 106 medication errors in which methotrexate was identified as the contributor were reported to the Food and Drug Administration between 1997 and 2001. Rheumatoid arthritis (42%) and psoriasis (12%) were the most common indications with 52% of the reported errors associated with a form of overdose (daily instead of weekly = 30%).…”
Section: Discussionmentioning
confidence: 99%
“…These medications are often involved in clinically relevant interactions or have a narrow therapeutic window [4][5][6][7]. • Patients with renal impairment (creatinine clearance Cockcroft-Gault \ 60 ml/min [8,9]).…”
Section: Methodsmentioning
confidence: 99%
“…Methotrexate is FDA approved for use in managing rheumatoid arthritis (RA), certain neoplastic diseases, and recalcitrant psoriasis and is prescribed for daily or weekly administration based on the indication for use . Oral methotrexate, when used for RA, is associated with “wrong frequency error,” with daily instead of the intended weekly dosing schedule . Wrong frequency errors result from physician prescribing, pharmacist dispensing, and patient and caregiver administration.…”
Section: Introductionmentioning
confidence: 99%